Navigation Links
Chem Rx Corporation Appoints Gary M. Jacobs Chief Financial Officer
Date:6/16/2008

LONG BEACH, N.Y., June 16 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of institutional pharmacy services, announced today the appointment of Gary M. Jacobs as the Company's Chief Financial Officer. Mr. Jacobs is an experienced finance professional with a background that includes corporate finance, SEC reporting and public accounting. Chem Rx also announced the resignation of its interim Chief Financial Officer, Joseph Sinicropi, effective immediately.

Jerry Silva, Chairman and Chief Executive Officer of Chem Rx Corporation, stated, "We are very pleased to welcome Gary Jacobs to the Chem Rx team. Gary's public company background, operations experience and understanding of financial markets will benefit our company as we continue our efforts to grow the business and implement new financial and accounting procedures and controls."

Mr. Jacobs remarked, "I look forward to joining the Chem Rx senior management team. My experience with implementing financial accounting systems and managing a public company's financial team will be valuable as I address my top priority of improving Chem Rx's financial controls."

Mr. Jacobs has over 30 years of experience in accounting, finance and operations. Since May 2005, he has been Chief Financial Officer and Chief Operating Officer of Karat Platinum LLC, which supplies and develops jewelry products. Karat Platinum LLC is a publicly held company, formerly known as Sentra Consulting Corp. Prior to that, Mr. Jacobs was President of The Innovative Companies, LLC, a supplier of natural stone; Executive Vice President of Operations and Corporate Secretary of The Hain Celestial Group, Inc., a publicly held food and personal care products company, where he also served as Executive Vice President of Finance, Chief Financial Officer and Treasurer prior to becoming Executive Vice President; Chief Financial Officer of Graham Field Health Products, Inc., a publicly held manufacturing and distribution company; and a member of the audit staff of Ernst & Young LLP, where he attained the position of senior manager. He is a certified public accountant and holds a Bachelor's of Business Administration in Accounting from Adelphi University.

About Chem Rx

Founded more than 40 years ago, Chem Rx is a major institutional pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, Pennsylvania and Florida. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx annually provides over six million prescriptions to more than 65,000 residents of more than 400 institutional facilities. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Chem Rx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward- looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx Corporation's filings with the SEC. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.

Contacts:

Steven C. Silva

President and Chief Operating Officer

Chem Rx Corporation

516-889-8770

Stephanie Carrington / Jared Hoffman

The Ruth Group

646-536-7017 / 7013

scarrington@theruthgroup.com

jhoffman@theruthgroup.com


'/>"/>
SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
2. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
3. Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration
4. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
5. Linkwell Corporation Disinfection Epidemic Prevention Teams Enter into Sichuan Earthquake Area
6. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
7. ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
8. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
9. Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado
10. Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop
11. AGA Medical Corporation Agrees to Pay $2 Million Penalty and Enter Deferred Prosecution Agreement for FCPA Violations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
Breaking Medicine Technology: